OM
Outset Medical, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Buy
+31/100
Last price
4.09
▼ 0.01 (0.24%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
4.26
Prev close
4.10
Day high
4.34
Day low
4.05
Volume
376.61K
Market cap
$77.82M
P/E (TTM)
—
52W range
2.84 – 16.16
Day trading desk
Gap from prior close
+3.90%
Prior close 4.10
VWAP
4.17
-1.92% from price
Relative volume
1.68×
Unusually busy
Session range
10.64%
4.05 – 4.48
Position in range
9%
Near session low
ATR (14D)
0.27
6.53% of price
Prior day high
4.16
PDH
Prior day low
3.85
PDL
Bid / ask spread
—
Quote not published
Session volume
264.12K
Avg 157.49K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+36.63%
+34.7%
1M
+15.32%
+14.2%
3M
-3.72%
-8.2%
6M
+0.98%
-17.2%
YTD
+11.59%
-2.7%
1Y
-71.43%
-87.8%
3Y
-97.46%
-179.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on OM open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+1.17M
Net buying
Buy transactions
13
1.21M shares
Sell transactions
8
36.63K shares
Net transactions
+21
Buys less sells
Sell : buy shares
0.0 : 1
Mixed
Insider-held shares
1.03M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 17, 26 | TRIGG LESLIE L Chief Executive Officer |
SELL | 3.44K | $15.09K | Direct |
| Aug 17, 26 | GAETA RENEE Chief Financial Officer |
SELL | 4.54K | $19.94K | Direct |
| Aug 17, 26 | BROTTEM JOHN L. General Counsel |
SELL | 2.63K | $11.55K | Direct |
| Jun 26, 26 | TRIGG LESLIE L Chief Executive Officer |
STOCK | 99.16K | $0 | Direct |
| Jun 26, 26 | GAETA RENEE Chief Financial Officer |
STOCK | 71.63K | $0 | Direct |
| Jun 26, 26 | BROTTEM JOHN L. General Counsel |
STOCK | 59.83K | $0 | Direct |
| Jun 4, 26 | GROSSMAN DONALD KEITH Director |
STOCK | 10.67K | $0 | Direct |
| Jun 4, 26 | HACKETT PATRICK T. Director |
STOCK | 10.67K | $0 | Direct |
| Jun 4, 26 | DREXLER KAREN Director |
STOCK | 10.67K | $0 | Direct |
| Jun 4, 26 | LANG BRENT D Director |
STOCK | 10.67K | $0 | Direct |
| Jun 4, 26 | PRANGE KAREN N. Director |
STOCK | 10.67K | $0 | Direct |
| Jun 4, 26 | O'BOYLE KEVIN C Director |
STOCK | 10.67K | $0 | Direct |
| Jun 3, 26 | GAETA RENEE Chief Financial Officer |
SELL | 17.67K | $87.30K | Direct |
| May 15, 26 | TRIGG LESLIE L Chief Executive Officer |
SELL | 3.44K | $12.75K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BROTTEM JOHN L. |
General Counsel | 87.47K | Sale |
ELLIOTT DERICK A |
Officer | 96.00K | Stock Award(Grant) |
GAETA RENEE |
Chief Financial Officer | 180.84K | Sale |
GROSSMAN DONALD KEITH |
Director | 37.43K | Stock Award(Grant) |
HACKETT PATRICK T. |
Director | 230.84K | Stock Award(Grant) |
LANG BRENT D |
Director | 45.18K | Stock Award(Grant) |
LEONARD BRADEN MICHAEL |
Beneficial Owner of more than 10% of a Class of Security | — | Conversion of Exercise of derivative security |
NASH MARC |
Officer | 38.39K | Sale |
O'BOYLE KEVIN C |
Director | 34.78K | Stock Award(Grant) |
TRIGG LESLIE L |
Chief Executive Officer | 236.85K | Sale |
Fundamentals
Market cap$77.82M
Enterprise value$35.08M
Revenue (TTM)$117.80M
Gross profit$49.20M
EBITDA$-62.73M
Net income$-74.29M
EPS (TTM)$-4.00
Free cash flow$-14.68M
Total cash$147.19M
Total debt$104.45M
Book value / share$5.13
Shares outstanding18.80M
Float14.77M
Short % of float6.40%
Dividend yield0.00%
Beta (5Y)1.99
Valuation & profitability ratios
Trailing P/E—
Forward P/E-1.81
PEG ratio—
Price / sales—
Price / book0.81
EV / revenue0.30
EV / EBITDA-0.56
Gross margin41.76%
Operating margin-49.55%
Profit margin-63.06%
Return on equity-59.17%
Return on assets-15.54%
Debt / equity108.42
Current ratio5.19
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $119.48M | $113.69M | $130.38M | $115.38M | +5.1% |
| Operating revenue | $119.48M | $113.69M | $130.38M | $115.38M | +5.1% |
| Cost of revenue | $72.72M | $75.13M | $101.38M | $97.54M | -3.2% |
| Gross profit | $46.75M | $38.56M | $29.00M | $17.83M | +21.2% |
| Research & development | $21.23M | $38.40M | $57.31M | $48.85M | -44.7% |
| Selling, general & admin | $92.22M | $113.54M | $141.46M | $130.00M | -18.8% |
| Total operating expense | $113.46M | $151.94M | $198.77M | $178.85M | -25.3% |
| Operating income | -$66.71M | -$113.38M | -$169.77M | -$161.02M | +41.2% |
| Net interest income | -$6.54M | -$14.11M | -$2.50M | -$275.00K | +53.6% |
| Pre-tax income | -$80.94M | -$127.48M | -$172.27M | -$162.66M | +36.5% |
| Tax provision | $718.00K | $491.00K | $523.00K | $295.00K | +46.2% |
| Net income | -$81.65M | -$127.98M | -$172.80M | -$162.96M | +36.2% |
| Net income to common | -$81.65M | -$127.98M | -$172.80M | -$162.96M | +36.2% |
| Basic EPS | -5.37 | -36.90 | -52.20 | -50.70 | +85.4% |
| Diluted EPS | -5.37 | -36.90 | -52.20 | -50.70 | +85.4% |
| EBIT | -$66.98M | -$103.61M | -$159.60M | -$159.09M | +35.4% |
| EBITDA | -$62.64M | -$97.89M | -$153.79M | -$153.93M | +36.0% |
| Basic shares | 15.21M | 3.46M | 3.31M | 3.21M | +339.2% |
| Diluted shares | 15.21M | 3.46M | 3.31M | 3.21M | +339.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $35.01M | $124.01M | $68.51M | $73.22M | -71.8% |
| Cash & short-term investments | $168.95M | $158.69M | $203.32M | $287.50M | +6.5% |
| Accounts receivable | $28.33M | $35.62M | $32.98M | $28.07M | -20.5% |
| Inventory | $47.61M | $59.39M | $49.22M | $51.48M | -19.8% |
| Total current assets | $250.88M | $258.22M | $291.22M | $373.64M | -2.8% |
| Property, plant & equipment | $9.47M | $12.07M | $18.65M | $21.99M | -21.6% |
| Total assets | $264.50M | $275.80M | $313.80M | $400.12M | -4.1% |
| Total current liabilities | $37.63M | $45.38M | $55.32M | $51.95M | -17.1% |
| Long-term debt | $96.24M | $197.38M | $130.11M | $96.34M | -51.2% |
| Total debt | $101.25M | $201.86M | $136.19M | $103.23M | -49.8% |
| Total liabilities | $137.54M | $248.98M | $190.91M | $154.13M | -44.8% |
| Retained earnings | -$1.17B | -$1.09B | -$961.75M | -$788.95M | -7.5% |
| Shareholder equity | $126.95M | $26.82M | $122.89M | $245.99M | +373.4% |
| Working capital | $213.25M | $212.84M | $235.90M | $321.70M | +0.2% |
| Net tangible assets | $126.95M | $26.82M | $122.89M | $245.99M | +373.4% |
| Shares issued | 18.17M | 3.53M | 3.35M | 3.23M | +414.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$81.65M | -$127.98M | -$172.80M | -$162.96M | +36.2% |
| Depreciation & amortisation | $4.34M | $5.73M | $5.81M | $5.17M | -24.2% |
| Stock-based compensation | $15.62M | $29.36M | $38.63M | $27.20M | -46.8% |
| Change in working capital | $2.20M | -$25.69M | -$773.00K | -$21.14M | +108.6% |
| Operating cash flow | -$46.33M | -$116.30M | -$131.37M | -$145.73M | +60.2% |
| Capital expenditure | -$798.00K | -$912.00K | -$3.44M | -$8.32M | +12.5% |
| Investing cash flow | -$97.68M | $103.94M | $83.03M | -$66.30M | -194.0% |
| Financing cash flow | $55.50M | $67.87M | $43.65M | $72.90M | -18.2% |
| Free cash flow | -$47.13M | -$117.22M | -$134.81M | -$154.05M | +59.8% |
| End cash position | $38.84M | $127.34M | $71.84M | $76.53M | -69.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $31.64M | $27.86M | $28.87M | $29.43M | $31.42M | +13.5% |
| Operating revenue | $31.64M | $27.86M | $28.87M | $29.43M | $31.42M | +13.5% |
| Cost of revenue | $18.35M | $15.77M | $16.64M | $17.84M | $19.55M | +16.4% |
| Gross profit | $13.28M | $12.10M | $12.23M | $11.59M | $11.87M | +9.8% |
| Research & development | $5.45M | $5.62M | $5.05M | $5.38M | $5.29M | -3.0% |
| Selling, general & admin | $23.51M | $23.40M | $24.80M | $22.03M | $23.44M | +0.5% |
| Total operating expense | $28.96M | $29.01M | $29.86M | $27.40M | $28.73M | -0.2% |
| Operating income | -$15.68M | -$16.92M | -$17.63M | -$15.81M | -$16.86M | +7.3% |
| Net interest income | -$2.09M | -$1.84M | -$1.77M | -$1.62M | -$1.57M | -13.4% |
| Pre-tax income | -$17.76M | -$18.76M | -$19.40M | -$17.43M | -$18.44M | +5.3% |
| Tax provision | $220.00K | $217.00K | $95.00K | $404.00K | $104.00K | +1.4% |
| Net income | -$17.98M | -$18.98M | -$19.49M | -$17.84M | -$18.54M | +5.2% |
| Net income to common | -$17.98M | -$18.98M | -$19.49M | -$17.84M | -$18.54M | +5.2% |
| Basic EPS | -0.97 | -1.03 | -1.09 | -1.00 | -1.04 | +5.8% |
| Diluted EPS | -0.97 | -1.03 | -1.09 | -1.00 | -1.04 | +5.8% |
| EBIT | -$14.32M | -$15.39M | -$15.96M | -$13.96M | -$14.96M | +7.0% |
| EBITDA | -$13.70M | -$14.60M | -$15.07M | -$12.95M | -$13.81M | +6.2% |
| Basic shares | 18.62M | 18.37M | 17.82M | 17.78M | 17.74M | +1.3% |
| Diluted shares | 18.62M | 18.37M | 17.82M | 17.78M | 17.74M | +1.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $35.01M | $30.56M | $35.01M | $36.44M | $39.56M | +14.5% |
| Cash & short-term investments | $147.19M | $156.71M | $168.95M | $178.64M | $184.09M | -6.1% |
| Accounts receivable | $29.22M | $25.32M | $28.33M | $32.96M | $34.89M | +15.4% |
| Inventory | $47.31M | $49.65M | $47.61M | $49.29M | $52.25M | -4.7% |
| Total current assets | $227.85M | $236.71M | $250.88M | $265.37M | $275.58M | -3.7% |
| Property, plant & equipment | $8.60M | $8.56M | $9.47M | $8.02M | $9.33M | +0.4% |
| Total assets | $242.38M | $249.45M | $264.50M | $277.25M | $288.80M | -2.8% |
| Total current liabilities | $43.89M | $37.61M | $37.63M | $37.45M | $36.91M | +16.7% |
| Long-term debt | $97.65M | $96.94M | $96.24M | $95.52M | $94.81M | +0.7% |
| Total debt | $104.45M | $101.61M | $101.25M | $98.68M | $98.43M | +2.8% |
| Total liabilities | $146.05M | $137.77M | $137.54M | $134.89M | $134.02M | +6.0% |
| Retained earnings | -$1.21B | -$1.19B | -$1.17B | -$1.15B | -$1.13B | -1.5% |
| Shareholder equity | $96.34M | $111.69M | $126.95M | $142.37M | $154.78M | -13.7% |
| Working capital | $183.96M | $199.10M | $213.25M | $227.92M | $238.67M | -7.6% |
| Net tangible assets | $96.34M | $111.69M | $126.95M | $142.37M | $154.78M | -13.7% |
| Shares issued | 18.80M | 18.53M | 18.17M | 17.81M | 17.77M | +1.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$17.98M | -$18.98M | -$19.49M | -$17.84M | -$18.54M | +5.2% |
| Depreciation & amortisation | $627.00K | $795.00K | $881.00K | $1.01M | $1.16M | -21.1% |
| Stock-based compensation | $2.70M | $3.45M | $4.06M | $5.08M | $3.50M | -21.9% |
| Change in working capital | $3.15M | $1.52M | $1.50M | $6.02M | $7.26M | +107.7% |
| Operating cash flow | -$9.63M | -$12.84M | -$9.52M | -$6.32M | -$4.82M | +25.0% |
| Capital expenditure | -$111.00K | -$65.00K | -$223.00K | -$160.00K | -$292.00K | -70.8% |
| Investing cash flow | $14.17M | $7.90M | $8.59M | $2.97M | -$31.16M | +79.3% |
| Financing cash flow | -$88.00K | $501.00K | $0 | $231.00K | -$384.00K | -117.6% |
| Free cash flow | -$9.75M | -$12.91M | -$9.74M | -$6.48M | -$5.12M | +24.5% |
| End cash position | $38.83M | $34.39M | $38.84M | $39.77M | $42.89M | +12.9% |
Options analytics
Put / call volume
4.60
Put-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
2.50
-39.6% from spot
ATM implied vol
25.0%
Nearest strike to spot
Skew (10% OTM)
+25.0%
Puts bid over calls
Call volume
10
Contracts, this expiry
Put volume
46
Contracts, this expiry
Heaviest call OI
5.00
0 contracts
Heaviest put OI
2.50
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.72 | -0.80 | -11.6% |
| Mar 2026 | -0.79 | -0.83 | -5.1% |
| Dec 2025 | -0.68 | -0.84 | -24.4% |
| Sep 2025 | -0.66 | -0.69 | -5.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.69 | 3 | $31.40M | +6.7% |
| Next quarter | -0.69 | 3 | $35.03M | +21.3% |
| Current year | -3.08 | 3 | $125.97M | +5.4% |
| Next year | -2.29 | 3 | $139.10M | +10.4% |
Analyst targets & ownership
Mean target$7.67
High target$10.00
Low target$6.00
Implied upside87.45%
Analyst count3
ConsensusBUY
Strong buy / Buy0 / 2
Hold1
Sell / Strong sell0 / 0
Held by insiders5.46%
Held by institutions73.90%
Institutions holding123
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
3.42
+19.56% from price
SMA 20
3.30
+25.32% from price
SMA 50
3.94
+4.95% from price
SMA 100
4.20
-2.59% from price
SMA 200
4.15
-0.24% from price
EMA 12
3.56
+14.83% from price
EMA 26
3.56
+14.94% from price
EMA 50
3.77
+8.61% from price
RSI (14)
66.4
Neutral
MACD (12,26,9)
0.00
Hist 0.17
ATR (14)
0.27
6.45% of price
Realised vol 30D
79.8%
Annualised
Bollinger upper
4.02
20, 2σ
Bollinger lower
2.58
20, 2σ
50 / 200 cross
Death
3.94 vs 4.15
Trend bias
Below 200
-0.24%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
2.05
More volatile than market
Correlation to SPY
0.26
Largely independent
Realised vol 30D
79.8%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-81.3%
Peak to trough
Max drawdown 5Y
-99.7%
Peak to trough
ATR 14
0.27
6.45% of price
Beta (reported)
1.99
5Y monthly, from filing
Short interest
Shares short
889.58K
Prior 936.34K
Change vs prior
-5.0%
Shorts covering
% of float
6.40%
Normal
% of shares out
4.73%
Against total outstanding
Days to cover
6.5
Crowded exit
Float
14.77M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 12, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jan 7, 26 | Stifel | MAINTAINED | Buy | Buy |
| Dec 16, 25 | BTIG | MAINTAINED | Buy | Buy |
| Nov 11, 25 | Stifel | MAINTAINED | Buy | Buy |
| Nov 11, 25 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Nov 11, 25 | BTIG | MAINTAINED | Buy | Buy |
| Aug 19, 25 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Aug 7, 25 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| May 21, 25 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| May 8, 25 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Jan 7, 25 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Aug 8, 24 | RBC Capital | DOWNGRADE | Outperform | Sector Perform |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split1:15
Split dateMar 20, 2025
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-28
Periodic Financial Reports
10-Q · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-06-17
Corporate Changes & Voting Matters
8-K · 2026-06-05
Corporate Changes & Voting Matters
8-K · 2026-05-29
Periodic Financial Reports
10-Q · 2026-05-07
Proxy Statements
DEF 14A · 2026-04-24
Periodic Financial Reports
10-K · 2026-02-13
Headlines
Can Fresenius Medical's 5008X Rollout Drive the Next Growth Phase?
Zacks · 33d ago
Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock
Zacks · 50d ago
Outset Medical (OM) Q2 2026 Earnings Call Transcript
Motley Fool · 54d ago
Osisko Metals (TSX:OM) Is Up 20.8% After Reporting Deepening 2026 Losses Has The Bull Case Changed?
Simply Wall St. · 60d ago
Outset Medical Q2 Earnings Call Highlights
MarketBeat · 61d ago
Outset Medical Inc (OM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Strategic HCA ...
GuruFocus.com · 61d ago
Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates
Zacks · 61d ago
Outset Medical Reports Second Quarter 2026 Results
GlobeNewswire · 61d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.